Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in Taiwan

Authors: Chieh-Lin Jerry Teng, Su-Peng Yeh, Tsai-Yun Chen, Yu-Chin Hung, Yun-Chu Lin, Sin Syue Li, Ming-Chung Wang, Shang-Yi Huang

Source: Hematology, Vol 29, Iss 1 (2024)

Subject Terms: Doublet and triplet regimen, pomalidomide, relapsed/refractory multiple myeloma, treatment pattern, Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: https://doaj.org/toc/1607-8454

Access URL: https://doaj.org/article/9593eb70b29941de9fe5b26697691dd5

Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan

Authors: Yu-Chin Hung, Jyh-Pyng Gau, Shang-Yi Huang, Bor-Sheng Ko, Chieh-Lin Jerry Teng

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: multiple myeloma, pomalidomide, treatment response, refractory, relapse, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.695410/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/45c2532c91da4c6385fdf44c07aace3f